News for Healthier Living
Study Identifies Potential Therapeutic Target Protein that Drives Metabolic Liver Disease Independent of Diet
Obesity-related metabolic liver disease affects hundreds of millions of people worldwide. New research found a protein, EFHD1, that drives liver damage by triggering an out-of-place antiviral immune response. Blocking EFHD1 can protect against liver injury in human cells and mouse models.
September 1, 2026
September 8 2026September 7 2026September 5 2026September 4 2026September 3 2026September 2 2026September 1 2026August 31 2026August 30 2026August 29 2026August 28 2026August 27 2026August 26 2026August 25 2026
|
|
|
|
|